Ephraim Heller
Ephraim Heller is an inventor and entrepreneur, and the current CEO of SynAgile Corporation.[1] SynAgile is developing new therapies for treatment of Parkinson's disease. In 1992, he was the co-founder and first CEO of TheraSense, which went[2] public and was later sold to Abbott Labs for $1.2 billion.[3] He was also co-founder, chairman and CEO of AngioScore and led the product development and FDA approval. AngioScore was acquired in 2014 for $230 million plus milestone payments. Prior to its acquisition, the company sold more than 300,000 AngioSculpt catheters in over 65 countries around the world. He was previously a venture partner at 7 Health Ventures. Heller holds an MBA from Yale School of Management and he has an AB in Physics from Harvard. His father is the engineer Adam Heller.
Patents[]
Ephraim Heller holds over 100 US patents, including patents on blood glucose monitors and photocatalytic materials.[4]
References[]
- ^ http://www.synagilepharma.com
- ^ "THERASENSE INC, Form S-1, Filing Date Oct 11, 2000" (PDF). secdatabase.com. Retrieved May 15, 2018.
- ^ "THE MARKETS: STOCKS & BONDS; Corporate Earnings Jitters Send Shares Modestly Lower". The New York Times. 14 January 2004.
- ^ http://search.usa.gov/search?affiliate=web-sdmg-uspto.gov&commit=Search&embedded=&filter=moderate&locale=en&m=&page=2&query=%22heller%2C+ephraim%22&sc=0&utf8=✓
External links[]
- Profile in Businessweek
- Abbott Labs: "In April 2004, Abbott announced it had completed the acquisition of TheraSense, a leader in developing blood glucose self-monitoring devices that require very small blood samples to deliver rapid test results".
- Abbott's Annual Report for Fiscal Year 2003 featured the acquisition of Therasense on its cover.
- New York Times, January 14, 2004: "A deal by Abbott Laboratories to buy TheraSense for $1.2 billion in cash to bolster its diabetes drugs sent TheraSense up 31 percent , gaining $6.34, to $26.64. Abbott rose 24 cents, to $44.43."
- Living people
- 20th-century American inventors
- 21st-century American inventors
- Harvard University alumni
- American health care chief executives
- Yale School of Management alumni